604 related articles for article (PubMed ID: 24046105)
1. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
2. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
3. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
6. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
7. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
9. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
Tan JC; McCready DR; Easson AM; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
[TBL] [Abstract][Full Text] [Related]
10. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
Ramzi S; Najeeb E; Coulthard J; Jenkins S
Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
[TBL] [Abstract][Full Text] [Related]
11. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
12. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
14. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ
Am J Surg; 2007 Aug; 194(2):172-5. PubMed ID: 17618799
[TBL] [Abstract][Full Text] [Related]
15. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
Pilewskie M; Karsten M; Radosa J; Eaton A; King TA
Ann Surg Oncol; 2016 Jul; 23(7):2229-34. PubMed ID: 26960927
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Prendeville S; Ryan C; Feeley L; O'Connell F; Browne TJ; O'Sullivan MJ; Bennett MW
Breast; 2015 Jun; 24(3):197-200. PubMed ID: 25681861
[TBL] [Abstract][Full Text] [Related]
17. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
18. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
Kósa C; Garami Z; Dinya T; Fülöp B
Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy during prophylactic mastectomy: is there a role?
Bunting PW; Cyr AE; Gao F; Margenthaler JA
J Surg Oncol; 2014 Jun; 109(8):747-50. PubMed ID: 24535940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
